Next Article in Journal
Methanol Extracts from Cirsium japonicum DC. var. australe Kitam. and Their Active Components Reduce Intracellular Oxidative Stress in Caenorhabditis elegans
Previous Article in Journal
New Monoterpene Glycoside Paeoniflorin Derivatives as NO and IL-1β Inhibitors: Synthesis and Biological Evaluation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Sabinene: A New Green Solvent Used in the Synthesis of Thiazolo[5,4-b]pyridines by Thermal or Microwave Activation

Institut de Chimie Organique et Analytique (ICOA), Université d’Orléans, UMR-CNRS 7311, BP 6759, rue de Chartres, 45067 Orléans, France
*
Author to whom correspondence should be addressed.
Molecules 2023, 28(19), 6924; https://doi.org/10.3390/molecules28196924
Submission received: 24 August 2023 / Revised: 29 September 2023 / Accepted: 2 October 2023 / Published: 3 October 2023

Abstract

:
Following the work already carried out in our laboratory on eucalyptol, a new green solvent derived from biomass, we are now looking at sabinene as another new green solvent. Sabinene is also derived from biomass, has no known toxicity and can be recycled by distillation. We have shown that it can be used as it is or distilled to synthesize thiazolo[5,4-b]pyridine heterocycles by thermal activation or microwave irradiation. This new solvent was compared with various conventional and green solvents. The conditions were optimised to enable us to carry out the syntheses in satisfactory yields, and we were able to show that sabinene, a natural bicyclic monoterpene, could be used effectively as a solvent.

Graphical Abstract

1. Introduction

Organic chemistry mainly uses petroleum-based products or solvents, which have a major impact on the environment. Today, it is important to preserve our non-renewable resources by using new types of solvents derived from biomass and to think about the economy of the atom. In 2019, we were able to highlight a new solvent derived from biomass, eucalyptol [1]. This has been compared with known conventional and green solvents and has shown an undeniable interest in the organic synthesis of numerous nitrogenous and sulphurous oxygenated heterocyclic compounds via, in particular, nucleophilic substitutions, cyclisations, various metal-catalysed couplings and multicomponent reactions [1,2,3,4,5]. Although we are still applying this new solvent in various synthetic processes, within the team we are continuing our efforts to limit our environmental impact and are therefore looking at other biomass-derived solvents. Sabinene 1 (Figure 1) is a compound in the family of unsaturated monoterpene hydrocarbons with the molecular formula C10H16. Sabinene is its trivial name, while its IUPAC name is 4-methylidene-1-(propan-2-yl)bicyclo[3.1.0]hexane. It is classified as a food additive and as a flavouring agent in the perfume industry. It is known for its anti-inflammatory, antioxidant, antifungal, [6,7], antiseptic, antimicrobial [8] and bactericidal properties [9].
Sabinene is either extracted from various plants or biosynthesised by enzymatic reaction [10]. It is naturally present in juniper (Juniperus Sabina) [11], marjoram (Origanum majorana) [12], holm oak (Quercus ilex) [13], Norway spruce (Picea abies), Douglas fir (Pseudotsuga menziesii) [14], spearmint (Mentha spicata)[15], angelica (Angelica archangelica, Apiaceae) [16], carrots (Daucus Carota) [17], black pepper (Piperaceae) [18], Clausena anisata (Wildd.) Hook.f. ex Benth. (Rutacea) [19] or the citrus family [7] and many others. Sabinene, present in certain citrus fruits, could therefore be obtained from waste products from the fruit juice industry. It was therefore interesting to test it for the organic synthesis of compounds for biological purposes, as its use as a solvent would contribute to the recycling of industrial waste.
Sabinene has also been reported as a starting material for advanced biofuels [20,21]. Here, it is used as a green solvent for the synthesis of various thiazolo[5,4-b]pyridines compared to eucalyptol or cyclopentyl methyl ether (CPME), limonene and citral.
On the one hand, heterocycles are widely present in many agrochemical and pharmaceutical products [22,23,24,25,26,27,28]. To date, the number of pharmaceutical products containing a heterocyclic part in their skeleton, and in particular bicyclic heterocycles, is estimated to be around 70%, hence the importance of mastering synthesis protocols and carrying them out under the safest possible conditions, for the development and production of new environmentally friendly drugs or agrochemical compounds [25,29,30,31]. On the other hand, thiazolo[5,4-b]pyridine analogues are known for their promising properties and are therefore the subject of various developments [32,33,34,35,36], particularly in oncology, as some analogues show very good inhibition (in the nanomolar range) of phosphoinositide 3-kinase (PI3K) [37]. This is an important target for survival, proliferation and differentiation, and therefore for targeted tumour therapy [38]. These compounds can be synthesised in several ways, depending on the functionalities envisaged, in particular on the 6-membered ring. They can also be synthesised in a single step from a chloronitropyridine and a suitably substituted thioamide or thiourea [39]. We chose to use the one-step method starting from a 3-amino-2-chloropyridine derivative and an isothiocyanate, a synthetic method already used when we investigated laser irradiation as a new activation method in organic synthesis [40]. This reaction was chosen because of the interest of this type of heterocycle, but also because while the reagents are soluble, the product precipitates out of the medium, making it easy to visualise its production.

2. Results and Discussion

2.1. Thiazolo-Pyridine Synthesis in Various Standard and Green Solvents

2.1.1. Optimisation in Various Solvents

On the basis of the results obtained in a previous study [40] involving coupling between 3-amino-2-chloropyridine 2a and phenyl isothiocyanate 3a to obtain N-phenylthiazolo[5,4-b]pyridin-2-amine 4a, the synthesis was first carried out in various conventional solvents before being performed in green solvents. To investigate the ranges and limits, the temperature was maintained at a set point of 110 °C for an internal temperature of 100 °C in a sealed tube for each experiment by conventional heating using a stirring plate. It was found that 4 h were required at this temperature in conventional solvents, and that increasing the reaction time did not provide any significant improvement. It should be noted that the product obtained is the HCl salt product already described by Atland and Molander [41], which exhibits a characteristic NMR spectrum. We tried to carry out the reaction in the presence of a base equivalent such as K2CO3, but the reaction proved inefficient under these conditions. The solution was to proceed in two stages, forming the product in salt form and then neutralising it in the presence of a base. We therefore continued our study without a base and formed the products in salt form.
As the yields obtained were moderate in both conventional and green solvents, we concentrated on the latter to optimise reaction time, using one equivalent of each reagent. While citral only led to a disappointing yield of 21% in 16 h, increasing the reaction time was beneficial for the other green solvents, allowing us to achieve satisfactory yields of 58 to 75% (Table 1, entries 7,9 and 11). Beyond 16 h, we did not observe any improvement in performance. We used sabinene as a new solvent and obtained encouraging results (Table 1, entries 10 and 11), although not as good as with eucalyptol or CPME (entries 6 to 9). Citral is a compound that does not behave very well at this temperature: the medium blackens as soon as the reaction temperature reaches 95 °C, whereas its boiling point is 229 °C (Table 1, entry 14). Given this degradation of the medium, we have not studied this solvent in depth, concentrating instead on sabinene and its comparison with eucalyptol, CPME and limonene.

2.1.2. Optimisation in Green Solvents

We therefore continued our optimisation in the previously mentioned green solvents before applying this new solvent (sabinene) to the synthesis of various compounds. The starting 3-amino-2-chloropyridine 2a (1.5 mmol) was heated in 1 mL of solvent in the presence of phenyl isothiocyanate 3a (Table 2). The yield was improved by increasing the amount of pyridine reagent (Table 2, entries 5, 9 and 12).
Since sabinene is commercially available at 75% purity (Merck, natural sabinene), we distilled it under reduced pressure with a membrane pump at 12 mbar, at 40 °C. However, we found that the reactions carried out in distilled or undistilled sabinene were unaffected and that the yields were equivalent, so we continued our study with commercially available undistilled sabinene.
To visualise the evolution of the reaction, the different phases, using 3-amino-2-chloropyridine 2a heated in 1 mL of sabinene in the presence of 4-bromophenyl isothiocyanate, were photographed at different reaction times, starting with the control after mixing the compounds, then during the heating period at 60 °C, after 5 min at 100 °C, after 30 min at 100 °C, then after 4 h at 100 °C, and finally after 24 h of reaction at 100 °C, where complete precipitation of the product could be seen (Figure 2).

2.2. Optimisation of Thiazolo-Pyridine Synthesis in Sabinene

Under Microwave Irradiation and Thermal Conditions

Based on these initial results, the reaction was carried out under the conditions described in Table 2, entry 12, in order to obtain the optimum yield. We then tried to reduce the reaction time by using microwave activation. The temperature was also adapted. After completion, the product was filtered and washed with ethyl acetate and diethyl ether, and no further purification was required (Table 3).
Under microwave irradiation, the best results were obtained in 1 h at 160 °C, close to the boiling point of sabinene. However, as this temperature is not compatible with all isothiocyanates, we tried to reduce the reaction temperature and found that at 130 °C, the time required was 2 h. As sabinene is not a polar solvent and therefore not the most interesting for microwave reactions, we used 25% of a co-solvent that increases this polarity and chose ethanol or acetonitrile, which has proved very interesting as a co-solvent in previous work under microwave irradiation [42]. It turns out that while ethanol offers no improvement, acetonitrile halves the reaction time at 130 °C, while increasing the yield very slightly (Table 3, entries 4 and 6).
We applied these optimised conditions to a number of isothiocyanates 3 starting with 3-amino-2-chloropyridine 2a under thermal or microwave activation. The results are summarised in Scheme 1.
Six new structures were synthesised and obtained in high yields and purity by thermal and microwave activation, the other four having already been obtained in a previous study [40]. Secondly, we investigated the use of other pyridines substituted with an alkyl-type electron donor group.
Using 3-amino-2-chloro-5-methylpyridine 2b and phenyl isothiocyanate 3a in a sealed tube with 1 mL of sabinene required heating to 160 °C under thermal conditions and took 16 h to achieve a satisfactory result. After the reaction, the mixture was filtered with ethyl acetate and the desired compound was synthesised in a 66% yield (Table 4, entry 5).
In this case, too, we obtained the product in salt form and the reaction temperature was increased due to the donor effect of the para at the chlorine atom, which could explain the lower reactivity of the latter given the mechanism of formation of 2-aminothiazolo[5,4-b]pyridine (Scheme 2).
This mechanism was validated by Atland and Molander [41] with the formation of thiourea, in which the tautomeric thione or thiol displaced the chlorine atom.
Under microwave irradiation, the best results were obtained using 1.1 equiv. 3-amino-2-chloro-5-methylpyridine 2b and 1 equiv. isothiocyanate 3, in a sealed tube with 1 mL sabinene. The reaction was carried out at 130 °C for 2 h to give a yield of 64% (Table 5, entry 7). Again, at the end of the reaction, the mixture was filtered and rinsed with ethyl acetate.
We applied these optimised conditions to certain isothiocyanates with 3-amino-2-chloro-5-methylpyridine 2b under thermal or microwave activation. The results are summarised in Scheme 3.
The use of 3-amino-2-chloro-5-methylpyridine 2b gives good yields when activated by conventional heating. The results remain lower under microwave irradiation, but enable the desired products to be generated more quickly. We were able to overcome the deactivating effect of methyl in this reaction by adjusting the conditions.
In parallel, we tested these conditions using phenyl isocyanate 6 to obtain the corresponding oxazolopyridines 8. However, as reported by Sun and co-workers [43], in this case and under our conditions, we also stopped at urea 7 (Scheme 4).

3. Materials and Methods

3.1. General Information

All reagents were purchased from commercial suppliers and used without further purification. Natural sabinene was purchased from Merck (KGaA, Darmstadt, Germany) with 75% of purity. Unless otherwise specified, sabinene was used in its commercial form. 1H and 13C NMR spectra were recorded on a Bruker DPX 250 (13C, 62.9 MHz) (Bruker, Wissembourg, France), Bruker Avance II 250.13 (13C, 63 MHz), Bruker Avance 400.13 (13C, 101 MHz) (Bruker, Wissembourg, France), or on a Bruker Avance III HD nanobay 400.13 (13C, 101 MHz) (Bruker, Wissembourg, France). Chemical shifts are expressed in parts per million (ppm) and were calibrated on deuterated or residual non-deuterated solvent peaks for 1H and 13C spectra. The following abbreviations are used for proton spectra multiplicities: b: broad, s: singlet, d: doublet, t: triplet, q: quartet, p: pentuplet, m: multiplet. Microwave-assisted reactions were carried out in a Biotage Initiator microwave synthesis instrument and temperatures were measured using an IR sensor (Biotage, Uppsala, Sweden). Melting points (p.m. (°C)) were taken on samples placed in open capillary tubes on a Thermo Fisher Melting Point Instrument Digital 9000 Series IA9200X6 and were not corrected. High-resolution mass spectra (HRMS) were performed on a Bruker 4G Maxis UHR-q-TOF mass spectrometer (Bruker, Wissembourg, France), with an electrospray ionization (ESI) mode. The numbering of the atoms on the molecules has been chosen arbitrarily and is indicated on the drawings of the molecules for a better understanding of the NMR spectra.

3.2. General Procedure (1)

The substituted 3-amino-2-chloropyridine 2 (1.65 mmol; 1.1 equiv.) and substituted isothiocyanate 3 (1.5 mmol; 1 equiv.) were dissolved in 1.0 mL of sabinene and stirred at 100 °C for 16 h. The mixture was allowed to cool to room temperature. The mixture was then filtered and washed with ethyl acetate followed by diethyl ether. The product was isolated without further purification.

3.3. General Procedure (2)

In a sealed tube, the substituted 3-amino-2-chloropyridine 2 (1.65 mmol ; 1.1 equiv.) and substituted isothiocyanate 3 (1.5 mmol ; 1 equiv.) were dissolved in 1.0 mL of sabinene. The mixture was placed under microwave irradiation for 2 h at 130 °C. The mixture was allowed to cool to room temperature. Then, the reaction was filtered and washed with ethyl acetate followed by diethyl ether. The product was isolated without further purification.

3.4. General Procedure (3)

In a sealed tube, the substituted 3-amino-2-chloropyridine 2 (1.65 mmol; 1.1 equiv.) and substituted isothiocyanate 3 (1.5 mmol; 1 equiv.) were dissolved in the solvent consisting of 0.75 mL sabinene and 0.25 mL acetonitrile. The mixture was placed under microwave irradiation for 2 h at 130 °C. After cooling to room temperature, the reaction mixture was filtered and washed with ethyl acetate followed by diethyl ether. The product was isolated without further purification.
N-phenylthiazolo[5,4-b]pyridin-2-amine hydrochloride (4a).
Molecules 28 06924 i005
Using general procedure (1) applied to phenyl isothiocyanate 3a and 3-amino-2-chloropyridine 2a. Yield: 65%. Beige solid, m.p. 273 °C. (Lit. 284–285 °C) [41]. 1H NMR (400 MHz, DMSO-d6) δ 7.07 (tt, J = 7.3, 1.2 Hz, 1H, 10HAr), 7.32–7.41 (m, 2H, 9HAr and 9′HAr), 7.42 (dd, J = 8.1, 5.0 Hz, 1H, 2HAr), 7.81 (dd, J = 7.5, 1.3 Hz, 2H, 8HAr and 8′HAr), 7.97 (dd, J = 8.2, 1.5 Hz, 1H, 3HAr), 8.29 (dd, J = 5.0, 1.5 Hz, 1H, 1HAr), 10.94 (bs, 1H, N-H). 13C NMR (101 MHz, DMSO-d6) δ 118.4 (8CHAr and 8′CHAr), 121.7 (2CHAr), 122.8 (10CHAr), 126.2 (3CHAr), 129.0 (9CHAr and 9′CHAr), 140.0 (7CIV), 141.8 (1CHAr), 146.5 (4CIV), 153.2 (5CIV) and 161.1 (6CIV). HRMS (m/z) (ESI+): calcd. for m/z C12H10N3S [M + H+] = 228.0590; found = 228.0588.
N-(4-chlorophenyl)thiazolo[5,4-b]pyridin-2-amine hydrochloride (4b).
Molecules 28 06924 i006
Using general procedure (1) applied to 4-chlorophenyl isothiocyanate and 3-amino-2-chloropyridine 2a. Yield: 59%. Beige solid, m.p. 258 °C. 1H NMR (DMSO-d6, 400 MHz): δH = 7.39–7.46 (m, 3H, 2HAr + 8HAr + 8′HAr), 7.86 (d, J = 8.0 Hz, 2H, 9HAr and 9′HAr), 7.98 (d, J = 8.2 Hz, 1H, 3HAr), 8.31 (d, J = 5.2 Hz, 1H, 1HAr), 11.23 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 119.8 (9CHAr and 9′CHAr), 121.8 (2CHAr), 126.2 (10CIV), 126.3 (3CHAr), 128.9 (8CHAr and 8′CHAr), 139.0 (7CIV), 142.2 (1CHAr), 146.3 (4CIV), 153.4 (5CIV) and 160.8 (6CIV). HRMS (m/z) (ESI+): calcd. for m/z C12H9ClN3S [M + H+] = 262.0200; found = 262.0198.
N-(3,5-bis(trifluoromethyl)phenyl)thiazolo[5,4-b]pyridin-2-amine hydrochloride (4c).
Molecules 28 06924 i007
Using general procedure (3) applied to 3,5-Bis(trifluoromethyl)phenyl isothiocyanate and 3-amino-2-chloropyridine 2a. Yield: 54%. Colourless solid, m.p. 231 °C. 1H NMR (DMSO-d6, 400 MHz): δ 7.43 (dd, J = 8.2, 4.9 Hz, 1H, 2HAr), 7.69 (s, 1H, 10HAr), 8.03 (d, J = 8.1 Hz, 1H, 3HAr), 8.34 (d, J = 4.9 Hz, 1H, 1HAr), 8.51 (s, 2H, 8HAr and 8′HAr), 11.89 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 114.8 (10CHAr), 117.6 (8CHAr and 8′CHAr), 121.8 (2CHAr), 123.3 (q, 1J = 274 Hz, 11CF3 and 11′CF3), 126.7 (3CHAr), 130.9 (q, 2J = 32 Hz, 9CIV and 9′CIV), 141.8 (7CIV), 143.6 (1CHAr), 145.3 (4CIV), 153.8 (5CIV) and 160.4 (6CIV). 19F NMR (DMSO-d6, 376 MHz): δ 61.66. HRMS (m/z) (ESI+): calcd. for m/z C14H8F6N3S [M + H+] = 364.0338; found = 364.0341.
N-(4-methoxyphenyl)thiazolo[5,4-b]pyridin-2-amine hydrochloride (4d).
Molecules 28 06924 i008
Using general procedure (1) applied to 4-methoxyphenyl isothiocyanate and 3-amino-2-chloropyridine 2a. Yield: 54%. Yellow solid, m.p. 241 °C. 1H NMR (DMSO-d6, 400 MHz): δ 3.74 (s, 3H, 11CH3-O), 6.96 (d, J = 7.0 Hz, 2H, 8CHAr and 8′CHAr), 7.41 (dd, J = 8.1, 5.0 Hz, 1H, 2CHAr), 7.69 (d, J = 7.0 Hz, 2H, 9CHAr and 9′CHAr), 7.93 (d, J = 8.1 Hz, 1H, 3CHAr), 8.27 (d, J = 5.1 Hz, 1H, 1CHAr), 10.93 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 55.3 (11CH3-O), 114.3 (8CHAr and 8′CHAr), 120.5 (9CHAr and 9′CHAr), 121.8 (2CHAr), 125.8 (3CHAr), 133.1 (7CIV), 141.1 (1CHAr), 146.7 (4CIV), 152.8 (5CIV), 155.3 (10CIV) and 161.6 (6CIV). HRMS (m/z) (ESI+): calcd. for m/z C13H12N3OS [M + H+] = 258.0695; found = 258.0693.
N-(4-bromophenyl)thiazolo[5,4-b]pyridin-2-amine hydrochloride (4e).
Molecules 28 06924 i009
Using general procedure (1) applied to 4-bromophenyl isothiocyanate and 3-amino-2-chloropyridine 2a. Yield: 66%. Beige solid, m.p. 264 °C (decomposition). 1H NMR (DMSO-d6, 400 MHz): δ 7.41 (dd, J = 8.1, 4.9 Hz, 1H, 2HAr), 7.55 (d, J = 8.8 Hz, 2H, 8HAr and 8′HAr), 7.80 (d, J = 8.9 Hz, 2H, 9HAr and 9′HAr), 7.97 (dd, J = 8.2, 1.6 Hz, 1H, 3HAr), 8.30 (dd, J = 4.9, 1.6 Hz, 1H, 1HAr), 11.16 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 114.1 (10CIV), 120.2 (9CHAr and 9′CHAr), 121.7 (2CHAr), 126.1 (3CHAr), 131.8 (8CHAr and 8′CHAr), 139.4 (7CIV), 142.5 (1CHAr), 146.1 (4CIV), 153.6 (5CIV) and 160.6 (6CIV). HRMS (m/z) (ESI+): calcd. for m/z C12H9BrN3S [M + H+] = 305.9695; found = 305.9698.
N-(3-bromophenyl)thiazolo[5,4-b]pyridin-2-amine hydrochloride (4f).
Molecules 28 06924 i010
Using general procedure (1) applied to 3-bromophenyl isothiocyanate and 3-amino-2-chloropyridine 2a. Yield: 58%. Yellowish solid, m.p. 231 °C. 1H NMR (DMSO-d6, 400 MHz): δ 7.23 (d, J = 8.1 Hz, 1H, 12HAr), 7.33 (t, J = 8.1 Hz, 1H, 11HAr), 7.41 (dd, J = 8.4, 5.2 Hz, 1H, 2HAr), 7.71 (d, J = 8.2 Hz, 1H, 10HAr), 7.99 (d, J = 8.1 Hz, 1H, 3HAr), 8.18 (s, 1H, 8HAr), 8.29 (d, J = 5.3 Hz, 1H, 1HAr), 11.12 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 117.2 (10CHAr), 120.5 (8CHAr), 121.8 (2CHAr), 121.9 (9CIV), 125.2 (12CHAr), 127.0 (3CHAr), 130.9 (11CHAr), 141.5 (1CHAr), 141.6 (7CIV), 146.5 (4CIV), 152.7 (5CIV) and 160.8 (6CIV). HRMS (m/z) (ESI+): calcd. for m/z C12H9BrN3S [M + H+] = 305.9695; found = 305.9689.
N-(3-chlorophenyl)thiazolo[5,4-b]pyridin-2-amine hydrochloride (4g).
Molecules 28 06924 i011
Using general procedure (1) applied to 3-chlorophenyl isothiocyanate and 3-amino-2-chloropyridine 2a. Yield: 63%. Beige solid, m.p. 205 °C. 1H NMR (DMSO-d6, 400 MHz): δ 7.10 (dd, J = 7.8, 2.4 Hz, 1H, 12HAr), 7.39 (t, J = 8.2 Hz, 1H, 11HAr), 7.44 (dd, J = 8.0, 4.9 Hz, 1H, 2HAr), 7.67 (dd, J = 8.2, 2.6 Hz, 1H, 10HAr), 8.03 (dd, J = 8.2, 1.6 Hz, 1H, 3HAr), 8.07 (m, 1H, 8HAr), 8.32 (dd, J = 4.9, 1.6 Hz, 1H, 1HAr), 11.32 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 116.7 (10CHAr), 117.6 (8CHAr), 121.8 (2CHAr), 122.3 (12CHAr), 126.5 (3CHAr), 130.6 (11CHAr), 133.3 (9CIV), 141.4 (7CIV), 142.4 (1CHAr), 146.1 (4CIV), 153.4 (5CIV) and 160.7 (6CIV). HRMS (m/z) (ESI+): calcd. for m/z C12H9ClN3S [M + H+] = 262.0200; found = 262.0202.
N-(3,5-dichlorophenyl)thiazolo[5,4-b]pyridin-2-amine hydrochloride (4h).
Molecules 28 06924 i012
Using general procedure (3) applied to 3,5-dichlorophenyl isothiocyanate and 3-amino-2-chloropyridine 2a. Yield: 66%. Beige solid, m.p. 265 °C (decomposition). 1H NMR (DMSO-d6, 400 MHz): δ 7.22 (t, J = 1.8 Hz, 1H, 10HAr), 7.43 (dd, J = 8.2, 4.9 Hz, 1H, 2HAr), 7.91 (d, J = 1.8 Hz, 2H, 8HAr and 8′HAr), 8.05 (dd, J = 8.2, 1.6 Hz, 1H, 3HAr), 8.33 (dd, J = 4.9, 1.6 Hz, 1H, 1HAr), 11.54 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 116.2 (8CHAr and 8′CHAr), 121.5 (10CHAr), 121.8 (2CHAr), 126.6 (3CHAr), 134.3 (9CIV and 9′CIV), 142.2 (7CIV), 143.2 (1CHAr), 145.6 (4CIV), 153.7 (5CIV) and 160.3 (6CIV). HRMS (m/z) (ESI+): calcd. for m/z C12H8Cl2N3S [M + H+] = 295.9811; found = 295.9810.
N-(ethyl 4-aminobenzoate)thiazolo[5,4-b]pyridin-2-amine hydrochloride (4i).
Molecules 28 06924 i013
Using general procedure (3) applied to ethyl 4-isothiocyanatobenzoate and 3-amino-2-chloropyridine 2a. Yield: 55%. Beige solid, m.p. 230 °C. 1H NMR (DMSO-d6, 400 MHz): δ 1.31 (t, J = 7.1 Hz, 3H, 13CH3), 4.28 (q, J = 7.1 Hz, 2H, 12CH2), 7.45 (dd, J = 8.1, 4.9 Hz, 1H, 2HAr), 7.96 (s, 4H, HAr), 8.04 (d, J = 8.3 Hz, 1H, 3HAr), 8.34 (d, J = 4.9 Hz, 1H, 1HAr), 11.48 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 14.3 (13CH3), 60.4 (12CH2), 117.6 (2xCHAr), 121.8 (2CH), 123.5 (10CIV), 126.8 (3CH), 130.5 (2xCHAr), 142.6 (1CH), 144.2 (7CIV), 146.1 (4CIV), 153.5 (5CIV), 160.5 (6CIV) and 165.3 (11CIV=O). HRMS (m/z) (ESI+): calcd. for m/z C15H14N3O2S [M + H+] = 300.0801; found = 300.0801.
N-methylthiazolo[5,4-b]pyridin-2-amine hydrochloride (4j).
Molecules 28 06924 i014
Using general procedure (1) applied to methyl isothiocyanate and 3-amino-2-chloropyridine 2a. Yield: 50%. Beige solid, m.p. 239 °C (lit. 264–265) [41]. 1H NMR (DMSO-d6, 400 MHz): δ 3.06 (s, 3H, 7CH3), 7.43 (dd, J = 8.1, 5.0 Hz, 1H, 2HAr), 7.88 (d, J = 8.1 Hz, 3HAr), 8.27 (d, J = 5.0 Hz, 1H, 1HAr), 9.69 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 30.9 (7CH3), 122.0 (2CHAr), 123.7 (3CHAr), 141.6 (1CHAr), 142.4 (4CIV), 150.6 (5CIV) and 165.9 (6CIV). HRMS (m/z) (ESI+): calcd. for m/z C7H8N3S [M + H+] = 166.0433; found = 166.0438.
N-benzamidethiazolo[5,4-b]pyridin-2-amine hydrochloride (4k).
Molecules 28 06924 i015
Using general procedure (1) applied to benzoyl isothiocyanate and 3-amino-2-chloropyridine 2a. Yield: 46%. Beige solid, m.p. 183 °C. 1H NMR (DMSO-d6, 400 MHz): δ 7.54 (dd, J = 8.2, 4.6 Hz, 1H, 2HAr), 7.58 (t, J = 7.6 Hz, 2H, 10HAr and 10′HAr), 7.67–7.71 (m, 1H, HAr), 8.11–8.20 (m, 3H, 9HAr + 9′HAr + 3HAr), 8.52 (dd, J = 4.8, 1.4 Hz, 1.0H, 1HAr), 12.95 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 121.8 (2CHAr), 127.6 (3CHAr), 128.4 (9CHAr and 9′CHAr), 128.7 (10CHAr and 10′CHAr), 131.6 (8CIV), 133.1 (11CHAr), 141.8 (4CIV), 145.4 (1CHAr), 154.7 (5CIV), 158.4 (6CIV) and 166.3 (7CIV=O). HRMS (m/z) (ESI+): calcd. for m/z C13H10N3OS [M + H+] = 256.0539; found = 256.0541.
N-phenylthiazolo[5,4-b]-6-methylpyridin-2-amine hydrochloride (5a).
Molecules 28 06924 i016
Using general procedure (2) applied to phenyl isothiocyanate 3a and 3-amino-2-chloro-5-methylpyridine 2b. Yield: 64%. Beige solid, m.p. 228 °C (decomposition). 1H NMR (DMSO-d6, 400 MHz): δ 2.38 (s, 3H, 2′CH3), 7.06 (t, J = 7.4 Hz, 1H, 10HAr), 7.38 (t, J = 7.6 Hz, 2H, 9HAr and 9′HAr), 7.80 (d, J = 8.3 Hz, 2H, 8HAr and 8′HAr), 7.88 (s, 1H, 3HAr), 8.20 (s, 1H, 1HAr), 10.93 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 17.8 (2′CH3), 118.5 (8CHAr and 8′CHAr), 122.9 (10CHAr), 127.4 (3CHAr), 129.1 (9CHAr and 9′CHAr), 131.7 (2CIV), 140.0 (7CIV), 141.2 (1CHAr), 146.9 (4CIV), 149.4 (5CIV) and 161.5 (6CIV). HRMS (m/z) (ESI+): calcd. for m/z C13H12N3S [M + H+] = 242.0746; found = 242.0749.
N-(3-bromophenyl)thiazolo[5,4-b]-6-methylpyridin-2-amine hydrochloride (5b).
Molecules 28 06924 i017
Using general procedure (1) applied to 3-bromophenyl isothiocyanate and 3-amino-2-chloro-5-methylpyridine 2b. Yield: 62%. Beige solid, m.p. 247–248 °C. 1H NMR (DMSO-d6, 400 MHz): δ 2.38 (s, 3H, 2′CH3), 7.23 (d, J = 7.8 Hz, 1H, 12HAr), 7.32 (t, J = 7.9 Hz, 1H, 11HAr), 7.69 (d, J = 8.1 Hz, 1H, 10HAr), 7.91 (s, 1H, 3HAr), 8.20 (s, 2H, 1HAr and 8HAr), 11.26 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 17.8 (2′CH3), 117.0 (10CHAr), 120.4 (8CHAr), 121.8 (9CIV), 125.1 (12CHAr), 127.3 (3CHAr), 130.9 (11CHAr), 131.6 (2CIV), 141.5 (7CIV), 142.5 (1CHAr), 146.2 (4CIV), 150.1 (5CIV) and 160.9 (6CIV). HRMS (m/z) (ESI+): calcd. for m/z C13H11BrN3S [M + H+] = 319.9852; found = 319.9847.
N-(3,5-bis(trifluoromethyl)phenyl)thiazolo[5,4-b]-6-methylpyridin-2-amine hydrochloride (5c).
Molecules 28 06924 i018
Using general procedure (2) applied to 3,5-Bis(trifluoromethyl)phenyl isothiocyanate and 3-amino-2-chloro-5-methylpyridine 2b. Yield: 48%. Beige solid, m.p. 242 °C (decomposition). 1H NMR (DMSO-d6, 400 MHz): δ 2.37 (s, 3H, 2′CH3), 7.67 (s, 1H, 11HAr), 7.89 (s, 1H, 3HAr), 8.19 (s, 1H, 1HAr), 8.49 (s, 2H, 8CHAr and 8′CHAr), 11.83 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 17.7 (2′CH3), 114.8 (11CHAr), 117.6 (8CHAr and 8′CHAr), 123.3 (q, 1J = 274 Hz, 10CF3 and 10′CF3), 127.3 (3CHAr), 130.9 (q, 2J = 33 Hz, 9CIV and 9′CIV), 131.6 (2CIV), 141.8 (7CIV), 143.9 (1CHAr), 145.3 (4CIV), 150.6 (5CIV) and 160.6 (6CIV). 19F NMR (DMSO-d6, 376 MHz):δ -61.68. HRMS (m/z) (ESI+): calcd. for m/z C15H10F6N3S [M + H+] = 378.0494; found = 378.0491.
N-(4-methoxyphenyl)thiazolo[5,4-b]-6-methylpyridin-2-amine hydrochloride (5d).
Molecules 28 06924 i019
Using general procedure (2) applied to 4-methoxyphenyl isothiocyanate and 3-amino-2-chloro-5-methylpyridine 2b. Yield: 42%. Yellow solid, m.p. 212 °C (decomposition). 1H NMR (DMSO-d6, 400 MHz): δ 2.37 (s, 3H, 2′CH3), 3.75 (s, 3H, 11CH3-O), 6.96 (d, J = 9.0 Hz, 2H, 8HAr and 8′HAr), 7.67 (d, J = 9.0 Hz, 2H, 9HAr and 9′HAr), 7.84 (s, 1H, 3HAr), 8.17 (s, 1H, 1HAr), 10.80 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 17.8 (2′CH3), 55.3 (11CH3-O), 114.3 (8CHAr and 8′CHAr), 120.6 (9CHAr and 9′CHAr), 127.0 (3CHAr), 131.8 (2CIV), 133.1 (7CIV), 140.5 (1CHAr), 147.0 (4CIV), 149.1 (5CIV), 155.4 (10CIV) and 162.1 (6CIV). HRMS (m/z) (ESI+): calcd. for m/z C14H14N3OS [M + H+] = 272.0852; found = 272.0856.
N-(3,5-dichlorophenyl)thiazolo[5,4-b]-6-methylpyridin-2-amine hydrochloride (5e).
Molecules 28 06924 i020
Using general procedure (2) applied to 3,5-dichlorophenyl isothiocyanate and 3-amino-2-chloro-5-methylpyridine 2b. Yield: 59%. Pinkish solid, m.p. 251 °C. 1H NMR (DMSO-d6, 250 MHz): δ 2.37 (s, 3H, 2′CH3), 7.21 (t, J = 1.9 Hz, 1H, 10HAr), 7.89 (d, J = 1.9 Hz, 2H, 8HAr and 8′HAr), 7.93 (d, J = 1.0 Hz, 1H, 3HAr), 8.20 (d, J = 1.2 Hz, 1H, 1HAr), 11.51 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 17.7 (2′CH3), 116.1 (8CHAr and 8′CHAr), 121.4 (10CHAr), 127.4 (3CHAr), 131.6 (2CIV), 134.2 (9CIV and 9′CIV), 142.2 (7CIV), 143.2 (1CHAr), 145.7 (4CIV), 150.3 (5CIV) and 160.6 (6CIV). HRMS (m/z) (ESI+): calcd. for m/z C13H10Cl2N3S [M + H+] = 309.9967; found = 309.9973.
N-(3-chlorophenyl)thiazolo[5,4-b]-6-methylpyridin-2-amine hydrochloride (5f).
Molecules 28 06924 i021
Using general procedure (1) applied to 3-chlorophenyl isothiocyanate and 3-amino-2-chloro-5-methylpyridine 2b. Yield: 67%. Colourless solid, m.p. 214 °C. 1H NMR (DMSO-d6, 400 MHz): δ 2.38 (s, 3H, 2′CH3), 7.09 (dd, J = 8.0, 2.3 Hz, 1H, 10HAr), 7.38 (t, J = 8.0 Hz, 1H, 11HAr), 7.64 (dd, J = 8.2, 2.3 Hz, 1H, 12HAr), 7.93 (s, 1H, 3HAr), 8.08 (s, 1H, 8HAr), 8.21 (s, 1H, 1HAr), 11.34 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 17.8 (2′CH3), 116.7 (12CHAr), 117.6 (8CHAr), 122.2 (10CHAr), 127.6 (3CHAr), 130.6 (11CHAr), 131.7 (2CIV), 133.3 (9CIV), 141.4 (7CIV), 141.9 (1CHAr), 146.4 (4CIV), 149.7 (5CIV) and 161.0 (6CIV). HRMS (m/z) (ESI+): calcd. for m/z C13H11ClN3S [M + H+] = 276.0357; found = 267.0360.
N-benzamidethiazolo[5,4-b]-6-methyl-2-amine hydrochloride (5g).
Molecules 28 06924 i022
Using general procedure (1) applied to benzoyl isothiocyanate and 3-amino-2-chloro-5-methylpyridine 2b. Yield: 46%. Colourless solid, m.p. 222 °C. 1H NMR (DMSO-d6, 400 MHz): δ 2.43 (s, 3H, 2′CH3), 7.57 (t, J = 7.7 Hz, 2H, 10HAr and 10′HAr), 7.67 (t, J = 7.3 Hz, 1H, 11HAr), 7.97 (s, 1H, 3HAr), 8.13 (d, J = 7.8 Hz, 2H, 9HAr and 9′HAr), 8.35 (s, 1H, 1HAr), 12.91 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 17.9 (2′CH3), 127.7 (3CHAr), 128.4 (9CHAr and 9′CHAr), 128.7 (10CHAr and 10′CHAr), 131.5 (2CIV), 131.7 (8CIV), 133.1 (11CHAr), 141.7 (4CIV), 146.2 (1CHAr), 151.8 (5CIV), 158.6 (6CIV) and 166.2 (7CIV=O). HRMS (m/z) (ESI+): calcd. for m/z C14H12N3OS [M + H+] = 270.0696; found = 270.0698.
N-(ethyl 4-aminobenzoate)thiazolo[5,4-b]-6-methylpyridin-2-amine hydrochloride (5h).
Molecules 28 06924 i023
Using general procedure (1) applied to ethyl 4-isothiocyanatobenzoate and 3-amino-2-chloro-5-methylpyridine 2b. Yield: 64%. Beige solid, m.p. 210 °C (decomposition). 1H NMR (DMSO-d6, 400 MHz): δ 1.31 (t, J = 7.0 Hz, 3H, 13CH3), 2.38 (s, 3H, 2′CH3), 4.28 (q, J = 7.0 Hz, 2H, 12CH2), 7.89 (s, 1H, 3HAr), 7.89–7.98 (m, 4H, HAr), 8.20 (s, 1H, 1HAr), 11.41 (bs, 1H, N-H). 13C NMR (DMSO-d6, 101 MHz): δ 14.2 (13CH3), 17.8 (2′CH3), 60.4 (12CH2), 117.5 (2 x CHAr), 123.4 (10CIV), 127.4 (3CHAr), 130.5 (2 x CHAr), 131.6 (2CIV), 142.7 (1CH), 144.2 (7CIV), 146.1 (4CIV), 150.2 (5CIV), 160.8 (6CIV) and 165.3 (11CIV). HRMS (m/z) (ESI+): calcd. for m/z C16H16N3O2S [M + H+] = 314.0958; found = 314.0956.
N-methylthiazolo[5,4-b]-6-methylpyridin-2-amine hydrochloride (5i).
Molecules 28 06924 i024
Using general procedure (1) applied to methyl isothiocyanate and 3-amino-2-chloro-5-methylpyridine 2b. Yield: 40%. Colourless solid, m.p. 186 °C (decomposition). 1H NMR (D2O, 400 MHz): δ 2.39 (s, 3H, 2′CH3), 3.13 (s, 3H, 7CH3), 7.60 (s, 1H, 3HAr), 8.12 (s, 1H, 1HAr). 13C NMR (D2O, 101 MHz): δ 17.5 (2′CH3), 31.4 (7CH3), 124.3 (3CHAr), 134.2 (2CIV), 138.1 (CIV), 142.8 (1CHAr), 143.3 (CIV) and 167.7 (6CIV). HRMS (m/z) (ESI+): calcd. for m/z C8H10N3S [M + H+] = 180.0590; found = 180.0587.

4. Conclusions

Following our work on eucalyptol as a new green solvent, we show in this article that sabinene is also potentially usable as another new biomass-derived green solvent.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28196924/s1, Characterization data for obtained products and copies of 1H, 13C NMR spectra and HRMS. Reference [41] is cited in the Supplementary Materials.

Author Contributions

Conceptualization, G.M. and S.B-R.; methodology, G.M., V.F., E.C., L.B., A.A. and S.B.-R.; validation, G.M. and S.B.-R.; formal analysis, G.M., V.F., E.C., L.B., A.A. and S.B.-R.; investigation, G.M., V.F., E.C., L.B., A.A. and S.B.-R.; resources, G.M., V.F., E.C., L.B., A.A. and S.B-R.; data curation, G.M., V.F., E.C., L.B., A.A. and S.B.-R.; writing—original draft preparation, G.M. and S.B.-R.; writing—review and editing, G.M. and S.B.-R.; visualization, G.M., V.F., E.C., L.B., A.A. and S.B.-R.; supervision, G.M. and S.B.-R.; project administration, G.M. and S.B.-R.; funding acquisition, S.B.-R. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data are reported in the manuscript and Supplementary Materials.

Acknowledgments

This work was performed using the equipment of Orleans University and Institute of Organic and Analytical Chemistry; we would like to thank the Centre Val de Loire region for its general support.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds are available from the authors.

References

  1. Campos, J.F.; Scherrmann, M.-C.; Berteina-Raboin, S. Eucalyptol: A new solvent for the synthesis of heterocycles containing oxygen, sulfur and nitrogen. Green Chem. 2019, 21, 1531–1539. [Google Scholar] [CrossRef]
  2. Campos, J.F.; Berteina-Raboin, S. Eucalyptol, an all-purpose product. Catalysts 2022, 12, 48. [Google Scholar] [CrossRef]
  3. Campos, J.F.; Berteina-Raboin, S. Eucalyptol as bio-based solvent for Migita–Kosugi–Stille coupling reaction on O,S,N-heterocycles. Catal. Today 2020, 358, 138–142. [Google Scholar] [CrossRef]
  4. Campos, J.F.; Berteina-Raboin, S. Eucalyptol as a Bio-Based Solvent for Buchwald-Hartwig Reaction on O,S,N-Heterocycles. Catalysts 2019, 9, 840. [Google Scholar] [CrossRef]
  5. Campos, J.F.; Ferreira, V.; Berteina-Raboin, S. Eucalyptol: A bio-based solvent for the synthesis of O,S,N-Heterocycles. Application to Hiyama Coupling, Cyanation, and Multicomponent Reactions. Catalysts 2021, 11, 222. [Google Scholar] [CrossRef]
  6. Valente, J.; Zuzarte, M.; Gonçalves, M.J.; Lopes, M.C.; Cavaleiro, C.; Salgueiro, L.; Cruz, M.T. Antifungal, antioxidant and anti-inflammatory activities of Oenanthe crocata L. essential oil. Food Chem. Toxicol. 2013, 62, 349–354. [Google Scholar] [CrossRef]
  7. Yamasaki, Y.; Kunoh, H.; Yamamoto, H.; Akimitsu, K. Biological roles of monoterpene volatiles derived from rough lemon (Citrus Jambhiri Lush) in citrus defense. J. Gen. Plant. Pathol. 2007, 73, 168–179. [Google Scholar] [CrossRef]
  8. Asili, J.; Emami, A.; Rahimizadeh, M.; Fazli-Bazzaz, B.S.; Hassanzadeh, M. Chemical and Antimicrobial Studies of Juniperus Sabina L. and Juniperus foetidissima Willd. Essential Oils. J. Essent. Oil Bear. Plants 2013, 13, 25–36. [Google Scholar] [CrossRef]
  9. Sacchetti, G.; Maietti, S.; Muzzoli, M.; Scaglianti, M.; Manfredini, S.; Radice, M.; Bruni, R. Comparative evaluation of 11 essential oils of different origin as functional antioxidants, antiradicals and antimicrobials in foods. Food Chem. 2005, 91, 621–632. [Google Scholar] [CrossRef]
  10. Cao, Y.; Zhang, H.; Liu, H.; Liu, W.; Zhang, R.; Xian, M.; Liu, H. Biosynthesis and Production of Sabinene: Current State and Perspectives. Appl. Microbiol. Biotechnol. 2018, 102, 1535–1544. [Google Scholar] [CrossRef] [PubMed]
  11. Abdel-Kader, M.S.; Soliman, G.A.; Alqarni, M.H.; Hamad, M.A.; Foudah, A.I.; Alqasoumi, S.I. Chemical composition and protective effect of Juniperus sabina L. essential oil against CCl4 induced hepatotoxicity. Saudi Pharm. J. 2019, 27, 945–951. [Google Scholar] [CrossRef]
  12. Verma, R.S.; Padalia, R.C.; Chauhan, A.; Verma, R.K.; Ur Rahman, L.; Singh, A. Changes in the Essential Oil Composition of Origanum majorana L. during Post Harvest Drying. J. Essent. Oil-Bear. Plants 2016, 19, 1547–1552. [Google Scholar] [CrossRef]
  13. Dallali, S.; Zouaoui, R.; Dallali, D.; Jdidi, S.; Toumi, L. Determination of some biochemical parameters from leaves of Quercus ilex L.(Fagaceae), collected in Djabel Zagouan (Tunisia). Arab. J. Med. Aromat. Plants 2021, 7, 1–28. [Google Scholar]
  14. Jirovetz, L.; Buchbauer, G.; Stoyanova, A.; Metodiev, S. Seasonal Depending Variations of the Composition and Biological Activities of Douglas Fir (Pseudotsuga menziesii) Essential Oils from Bulgaria. Sci. Pharm. 2000, 68, 323–328. [Google Scholar] [CrossRef]
  15. Snoussi, M.; Noumi, E.; Trabelsi, N.; Flamini, G.; Papetti, A.; De Feo, V. Mentha spicata Essential Oil: Chemical Composition, Antioxidant and Antibacterial Activities against Planktonic and Biofilm Cultures of Vibrio spp. Strains. Molecules 2015, 20, 14402–14424. [Google Scholar] [CrossRef]
  16. Fraternale, D.; Flamini, G.; Ricci, D. Essential oil composition and antimicrobial activity of Angelica archangelica L. (Apiaceae) roots. J. Med. Food 2014, 17, 1043–1047. [Google Scholar] [CrossRef]
  17. ul Haq Wani, R.; Prasad, K. Nutritional and processing aspects of carrot (Daucus carota)—A review. SAJFTE 2015, 1, 1–14. [Google Scholar] [CrossRef]
  18. Oliveira, G.L.; Moreira, D.L.; Mendes, A.D.R.; Guimaraes, E.F.; Figueiredo, L.S.; Kaplan, M.A.C.; Martins, E.R. Growth study and essential oil analysis of Piper aduncum from two sites of Cerrado biome of Minas Gerais State, Brazil. Rev. Bras. Farmacogn. 2013, 23, 743–753. [Google Scholar] [CrossRef]
  19. Omara, T.; Kiprop, A.K.; Kosgei, V.J.; Kagoya, S. Clausena anisata (Willd.) Hook.f. ex Benth. (Rutaceae): Ethnomedicinal uses, phytochemistry, pharmacological activities, toxicity, and clinical application. Tradit. Med. Res. 2022, 7, 51–74. [Google Scholar] [CrossRef]
  20. Renninger, N.S.; Ryder, J.A.; Fisher, K.J. Jet Fuel Compositions and Methods of Making and Using Same. U.S. Patent 7942940, 20 November 2007. [Google Scholar]
  21. Peralta-Yahya, P.P.; Ouellet, M.; Chan, R.; Mukhopadhyay, A.; Keasling, J.D.; Lee, T.S. Identification and microbial production of a terpene-based advanced biofuel. Nat. Commun. 2011, 2, 483. [Google Scholar] [CrossRef]
  22. Balaban, A.T. Aromaticity as a Cornerstone of Heterocyclic Chemistry. Chem. Rev. 2004, 104, 2777–2812. [Google Scholar] [CrossRef]
  23. Scott, K.A.; Njardarson, J.T. Analysis of US FDA-Approved Drugs Containing Sulfur Atoms. Top. Curr. Chem. 2018, 376, 5. [Google Scholar] [CrossRef] [PubMed]
  24. Chhabria, M.T.; Patel, S.; Modi, P.; Brahmkshatriya, P.S. Thiazole: A Review on Chemistry, Synthesis and Therapeutic Importance of its Derivatives. Curr. Top. Med. Chem. 2016, 16, 2841–2862. [Google Scholar] [CrossRef]
  25. Vitaku, E.; Smith, D.T.; Njardarson, J.T. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J. Med. Chem. 2014, 57, 10257–10274. [Google Scholar] [CrossRef] [PubMed]
  26. Taylor, R.D.; MacCoss, M.; Lawson, A.D.G. Rings in Drugs. J. Med. Chem. 2014, 57, 5845–5859. [Google Scholar] [CrossRef] [PubMed]
  27. Kabir, E.; Uzzaman, M. A review on biological and medicinal impact of heterocyclic compounds. Results Chem. 2022, 4, 100606. [Google Scholar] [CrossRef]
  28. Kerru, N.; Gummidi, L.; Maddila, S.; Gangu, K.K.; Jonnalagadda, S.B. A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications. Molecules 2020, 25, 1909. [Google Scholar] [CrossRef]
  29. Gibson, S.; McGuire, R.; Rees, D.C. Principal Components Describing Biological Activities and Molecular Diversity of Heterocyclic Aromatic Ring Fragments. J. Med. Chem. 1996, 39, 4065–4072. [Google Scholar] [CrossRef]
  30. Kalaria, P.N.; Karad, S.C.; Raval, D.K. A Review on Diverse Heterocyclic Compounds as the Privileged Scaffolds in Antimalarial Drug Discovery. Eur. J. Med. Chem. 2018, 5, 917–936. [Google Scholar] [CrossRef]
  31. Taylor, A.P.; Robinson, R.P.; Fobian, Y.M.; Blakemore, D.C.; Jones, L.H.; Fadeyi, O. Modern Advances in Heterocyclic Chemistry in Drug Discovery. Org. Biomol. Chem. 2016, 14, 6611–6637. [Google Scholar] [CrossRef]
  32. Cee, V.J.; Frohn, M.; Lanman, B.A.; Golden, J.; Muller, K.; Neira, S.; Pickrell, A.; Arnett, H.; Buys, J.; Gore, A.; et al. Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5. ACS Med. Chem. Lett. 2011, 2, 107–112. [Google Scholar] [CrossRef] [PubMed]
  33. Rao, A.U.; Palani, A.; Chen, X.; Huang, Y.; Aslanian, R.G.; West, R.E., Jr.; Williams, S.M.; Wu, R.; Hwa, J.; Sondey, C.; et al. Synthesis and Structure–activity Relationships of 2-(1,4′-bipiperidin-1′-yl)thiazolopyridine as H3 Receptor Antagonists. Bioorg. Med. Chem. Lett. 2009, 19, 6176–6180. [Google Scholar] [CrossRef] [PubMed]
  34. Kale, M.G.; Raichurkar, A.; Hameed, P.S.; Waterson, D.; McKinney, D.; Manjunatha, M.R.; Kranthi, U.; Koushik, K.; Jena, L.K.; Shinde, V.; et al. Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase, B.J. Med. Chem. 2013, 56, 8834–8848. [Google Scholar] [CrossRef] [PubMed]
  35. Xie, X.; Li, H.; Wang, J.; Mao, S.; Xin, M.; Lu, S.; Mei, Q.; Zhang, S. Synthesis and Anticancer Effects Evaluation of 1-alkyl-3-(6-(2-methoxy-3-sulfonylaminopyridin-5-yl)benzo[d]thiazol-2-yl)urea as Anticancer Agents with Low Toxicity. Bioorg. Med. Chem. 2015, 23, 6477–6485. [Google Scholar] [CrossRef] [PubMed]
  36. Bebernitz, G.R.; Beaulieu, V.; Dale, B.A.; Deacon, R.; Duttaroy, A.; Gao, J.; Grondine, M.S.; Gupta, R.C.; Kakmak, M.; Kavana, M.; et al. Investigation of Functionally Liver Selective Glucokinase Activators for the Treatment of Type 2 Diabetes. J. Med. Chem. 2009, 52, 6142–6152. [Google Scholar] [CrossRef] [PubMed]
  37. Xia, L.; Zhang, Y.; Zhang, J.; Lin, S.; Zhang, K.; Tian, H.; Dong, Y.; Xu, H. Identification of Novel Thiazolo[5,4-b]Pyridine Derivatives as Potent Phosphoinositide 3-Kinase Inhibitors. Molecules 2020, 25, 4630. [Google Scholar] [CrossRef] [PubMed]
  38. Liu, P.; Cheng, H.; Roberts, T.M.; Zhao, J.J. Targeting the Phosphoinositide 3-kinase Pathway in Cancer. Nat. Rev. Drug Discov. 2009, 8, 627–644. [Google Scholar] [CrossRef]
  39. Sahasrabudhe, K.P.; Angels Estiarte, M.; Tan, D.; Zipfel, S.; Cox, M.; O’Mahony, D.J.R.; Edwards, W.T.; Duncton, M.A.J. A single-step preparation of thiazolo[5,4-b]pyridine- and thiazolo[5,4-c]pyridine derivatives from chloronitropyridines and thioamides, or thioureas. J. Heterocycl. Chem. 2009, 46, 1125–1131. [Google Scholar] [CrossRef]
  40. Jemili, R.; Campos, J.F.; Dumuis, N.; Rabat, H.; Semmar, N.; Berteina-Raboin, S. Laser Synthesis: A Solvent-Free Approach for the Preparation of Phenylthiazolo[5,4-b]Pyridine Derivatives. RSC Adv. 2021, 11, 5003–5007. [Google Scholar] [CrossRef]
  41. Atland, H.W.; Molander, G.A. A facile synthesis of 2-aminothiazolo[5,4-b] and 2-aminothiazolo[4,5-c]pyridines. J. Heterocycl. Chem. 1977, 14, 129–134. [Google Scholar] [CrossRef]
  42. Fînaru, A.; Berthault, A.; Besson, T.; Guillaumet, G.; Berteina-Raboin, S. Microwave-Assisted Solid-Phase Synthesis of 5-Carboxamido-N-acetyltryptamine Derivatives. Org. Lett. 2002, 4, 2613–2615. [Google Scholar] [CrossRef] [PubMed]
  43. Xu, D.; Xu, X.; Liu, Z.; Sun, L.-P.; You, Q. A general and efficient synthesis of 2-substituted Oxazolopyridines. Synlett 2009, 7, 1172–1174. [Google Scholar] [CrossRef]
Figure 1. Sabinene structure.
Figure 1. Sabinene structure.
Molecules 28 06924 g001
Figure 2. Visual evolution of a manipulation from time T = 0 at r.t. to time T = 24 h at 100 °C. 1: T = 0, reaction medium. 2: T = 60 °C during heating period. 3: after 5 min at 100 °C. 4: after 30 min at 100 °C. 5: after 4 h at 100 °C. 6: after 24 h at 100 °C.
Figure 2. Visual evolution of a manipulation from time T = 0 at r.t. to time T = 24 h at 100 °C. 1: T = 0, reaction medium. 2: T = 60 °C during heating period. 3: after 5 min at 100 °C. 4: after 30 min at 100 °C. 5: after 4 h at 100 °C. 6: after 24 h at 100 °C.
Molecules 28 06924 g002
Scheme 1. Thiazolo-pyridine synthesis in sabinene under thermal or microwave activation.
Scheme 1. Thiazolo-pyridine synthesis in sabinene under thermal or microwave activation.
Molecules 28 06924 sch001
Scheme 2. Mechanism of 2-amino thiazolo[5,4-b]pyridine formation.
Scheme 2. Mechanism of 2-amino thiazolo[5,4-b]pyridine formation.
Molecules 28 06924 sch002
Scheme 3. 6-methyl-thiazolo-pyridine synthesis in sabinene under thermal or microwave activation.
Scheme 3. 6-methyl-thiazolo-pyridine synthesis in sabinene under thermal or microwave activation.
Molecules 28 06924 sch003
Scheme 4. Synthesis of corresponding urea instead of desired oxazolopyridine.
Scheme 4. Synthesis of corresponding urea instead of desired oxazolopyridine.
Molecules 28 06924 sch004
Table 1. Optimisation time of reaction in various solvents.
Table 1. Optimisation time of reaction in various solvents.
Molecules 28 06924 i001
EntrySolventT (°C)Time (h)Yield (%)
1Acetone100460
2DCM100443
3Toluene100444
4Dioxane100444
5THF100443
6Eucalyptol100459
7Eucalyptol1001675
8CPME100463
9CPME1001671
10Sabinene100436
11Sabinene1001658
12Limonene100465
13Limonene1001670
14Citral1001621
Table 2. Optimising reaction time and reagent equivalence in green solvents.
Table 2. Optimising reaction time and reagent equivalence in green solvents.
Molecules 28 06924 i002
Entry2-chloro-3-amino-pyridine (Equiv.)Isothiocyanate
(Equiv.)
Reaction Time (h)TP (°C)SolventYields
1114100Eucalyptol59%
21116100Eucalyptol75%
3114100CPME63%
41116100CPME71%
51.1116100CPME79%
6114100Limonene65%
71116100Limonene70%
8114100Sabinene36%
91.114100Sabinene38%
1011.14100Sabinene33%
111116100Sabinene68%
121.1116100Sabinene76%
131.1116100Distilled Sabinene62%
141116100Distilled Sabinene58%
Table 3. Optimisation of the reaction conditions under microwaves.
Table 3. Optimisation of the reaction conditions under microwaves.
EntryReaction TimeTemperature (°C)Yield (%)Solvant
11 h16067Sabinene
22 h15059
32 h13055
44 h13062
52 h1304475:25 Sabinene/Ethanol
62 h1306475:25 Sabinene/ACN
Table 4. Optimisation from 3-amino-2-chloro-5-methylpyridine 2b under thermal conditions.
Table 4. Optimisation from 3-amino-2-chloro-5-methylpyridine 2b under thermal conditions.
Molecules 28 06924 i003
EntryReaction TimePyridine
(Equiv.)
Isothiocyanate
(Equiv.)
Rinsing SolventYieldNMR Observation
15 h11Diethyl ether46%Clear
25 h1.11Diethyl ether55%Parasite peak
35 h11.1Diethyl ether53%Parasite peak
416 h1.11Diethyl ether75%Parasite peak
516 h1.11Ethyl acetate66%Clear
Table 5. Optimisation under microwave irradiation.
Table 5. Optimisation under microwave irradiation.
Molecules 28 06924 i004
EntryReaction TimeTemperatureYield
130 min150 °C40%
21 h150 °C61%
31 h160 °C57%
42 h150 °C63%
62 h110 °C37%
72 h130 °C64%
81 h130 °C50%
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Messire, G.; Ferreira, V.; Caillet, E.; Bodin, L.; Auville, A.; Berteina-Raboin, S. Sabinene: A New Green Solvent Used in the Synthesis of Thiazolo[5,4-b]pyridines by Thermal or Microwave Activation. Molecules 2023, 28, 6924. https://doi.org/10.3390/molecules28196924

AMA Style

Messire G, Ferreira V, Caillet E, Bodin L, Auville A, Berteina-Raboin S. Sabinene: A New Green Solvent Used in the Synthesis of Thiazolo[5,4-b]pyridines by Thermal or Microwave Activation. Molecules. 2023; 28(19):6924. https://doi.org/10.3390/molecules28196924

Chicago/Turabian Style

Messire, Gatien, Véronique Ferreira, Emma Caillet, Lyana Bodin, Amélia Auville, and Sabine Berteina-Raboin. 2023. "Sabinene: A New Green Solvent Used in the Synthesis of Thiazolo[5,4-b]pyridines by Thermal or Microwave Activation" Molecules 28, no. 19: 6924. https://doi.org/10.3390/molecules28196924

APA Style

Messire, G., Ferreira, V., Caillet, E., Bodin, L., Auville, A., & Berteina-Raboin, S. (2023). Sabinene: A New Green Solvent Used in the Synthesis of Thiazolo[5,4-b]pyridines by Thermal or Microwave Activation. Molecules, 28(19), 6924. https://doi.org/10.3390/molecules28196924

Article Metrics

Back to TopTop